ArticleFrontiers in pharmacology2026

Heart failure reporting signals associated with concomitant mavacamten and CYP inhibitors in obstructive hypertrophic cardiomyopathy: a real-world pharmacovigilance study with propensity score matching.

Daqiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.